Prognostic Significance of Serum and Tissue Carcinoembryonic Antigen in Patients with Gastric Adenocarcinomas
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Carcinoembryonic antigen (CEA) is known to be elevated in nearly all solid malignancies. The prognostic role of CEA in gastric cancers however, is still controversial. We evaluated preoperative serum CEA levels and CEA expression from the resected tumor tissues to determine whether they have prognostic significance in gastric cancer patients. Materials and Methods: Medical records of 810 patients who underwent surgery for gastric adenocarcinoma from June, 1998 to February, 2002 in Kyungpook National University Hospital were reviewed. Serum CEA level was evaluated by radioimmunoassay preoperatively, and the cut-off level for positivity was 7.0 ng/ml. Labeled streptavidin-biotin peroxidase method was used to determine CEA expression from the gastric cancer tissues. Results: Serum and tissue CEA were positive in 9.3% and 91.1% of the patients, respectively. They had no correlation with each other. The positivity rate of serum CEA had positive correlation with invasion depth (p＜0.001), lymph node metastasis (p＜0.001), distant metastasis (p=0.006), and final stage (p＜0.001). Well differentiated tumors showed higher serum CEA positivity (p=0.002). Patients with positive serum CEA had higher recurrence rate (p＜0.001). Multivariate analysis showed significantly lower survival rate in patients with preoperative CEA levels over 7 ng/ml than those with lower levels (48.0% vs. 80.7%; p＜0.001). The positivity rates of tissue CEA were higher in advanced cancers (p=0.033) and in more advanced stages (p=0.029). Tissue CEA positivity showed no correlation with recurrence or survival. Conclusions: Preoperative serum CEA level had correlation with disease progression and survival in gastric cancer patients, and proved to be an independent prognostic factor. Tissue CEA expression in gastric cancers had no prognostic information. (Cancer Res Treat. 2008; 40:16-21)
Abstract
Purpose: Carcinoembryonic antigen (CEA) is known to be elevated in nearly all solid malignancies. The prognostic role of CEA in gastric cancers however, is still controversial. We evaluated preoperative serum CEA levels and CEA expression from the resected tumor tissues to determine whether they have prognostic significance in gastric cancer patients. Materials and Methods: Medical records of 810 patients who underwent surgery for gastric adenocarcinoma from June, 1998 to February, 2002 in Kyungpook National University Hospital were reviewed. Serum CEA level was evaluated by radioimmunoassay preoperatively, and the cut-off level for positivity was 7.0 ng/ml. Labeled streptavidin-biotin peroxidase method was used to determine CEA expression from the gastric cancer tissues. Results: Serum and tissue CEA were positive in 9.3% and 91.1% of the patients, respectively. They had no correlation with each other. The positivity rate of serum CEA had positive correlation with invasion depth (p＜0.001), lymph node metastasis (p＜0.001), distant metastasis (p=0.006), and final stage (p＜0.001). Well differentiated tumors showed higher serum CEA positivity (p=0.002). Patients with positive serum CEA had higher recurrence rate (p＜0.001). Multivariate analysis showed significantly lower survival rate in patients with preoperative CEA levels over 7 ng/ml than those with lower levels (48.0% vs. 80.7%; p＜0.001). The positivity rates of tissue CEA were higher in advanced cancers (p=0.033) and in more advanced stages (p=0.029). Tissue CEA positivity showed no correlation with recurrence or survival. Conclusions: Preoperative serum CEA level had correlation with disease progression and survival in gastric cancer patients, and proved to be an independent prognostic factor. Tissue CEA expression in gastric cancers had no prognostic information. (Cancer Res Treat. 2008; 40:16-21)
참고문헌 (25)
- Abelev GI, "Production of embryonal alpha-globulin by transplantable mouse hepatomas", Transplantation, 1, pp.174~80 (1963)
- Thomson DM, "The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system", Proc Natl Acad Sci USA, 64, pp.161~7 (1969)
- Yamao T., "Tumor markers CEA, CA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer", Jpn J Clin Oncol, 29, pp.550~5 (1999)
- Kelsen DP, "Gastric cancer", pp.36~7 (1996), Lippincott-Raven Publishers
- Hammarstrom S., "Antigenic sites in carcinoembryonic antigen", Cancer Res, 49, pp.4852~8 (1989)
- Schwartz MK, "Current status of tumour markers", Scand J Clin Lab Invest Suppl, 221, pp.5~14 (1995)
- Kodera Y., "The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer", Am J Gastroenterol, 91, pp.49~53 (1996)
- Nakane Y., "Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients", Cancer, 73, pp.2703~8 (1994)
- Nishida H., "Immunohistochemical localization of carcinoembryonic antigen (CEA) in gastric cancer--a comparative study between tissue CEA and plasma CEA", Nippon Geka Gakkai Zasshi, 84, pp.328~35 (1983)
- Tachibana M., "Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer", J Am Coll Surg, 187, pp.64~8 (1998)
- Hirai H., "A collaborative clinical study of carcinoembryonic antigen in Japan", Cancer Res, 37, pp.2267~74 (1977)
- "Carcinoembryonic antigen: its role as a marker in the management of cancer. A national institutes of health consensus development conference", Ann Intern Med, 94, pp.407~9 (1981)
- Martin EW Jr, "Carcinoembryonic antigen: clinical and histological aspects", Cancer, 37, pp.62~81 (1976)
- Hansen HJ, "Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer", Hum Pathol, 5, pp.139~47 (1974)
- Alexander JC, "Effect of age and cigarette smoking on carcinoembryonic antigen levels", JAMA, 235, pp.1975~9 (1976)
- Kojima O., "Correlation between carcinoembryonic antigen in gastric cancer tissue and survival of patients with gastric cancer", Gann, 75, pp.230~6 (1984)
- Wittekind C., "Localization of CEA, HCG, lysozyme, alpha-1-antitrypsin, and alpha-1- antichymotrypsin in gastric cancer and prognosis", Virchows Arch A Pathol Anat Histopathol, 409, pp.715~24 (1986)
- Sobin LH, "International Union against Cancer" (1997), Springer
- "Japanese Classification of Gastric Carcinoma - 2nd English Edition", Gastric Cancer, 1, pp.10~24 (1998)
- Tabuchi Y., "Carcinoembryonic antigen levels of portal blood in gastric cancer patients", J Surg Res, 47, pp.81~6 (1989)
- Kiyama T., "Changes in serum and tissue carcinoembryonic antigen with growth of a human gastric cancer xenograft in nude mice", Jpn J Cancer Res, 81, pp.58~62 (1990)
- Mori M., "Prognostic value of immunohistochemically identified CEA, SC, AFP, and S-100 proteinpositive cells in gastric carcinoma", Cancer, 62, pp.534~40 (1988)
- Nakane Y., "Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients", Cancer, 73, pp.2703~8 (1994)
- Sakamoto J., "Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection", Surg Oncol, 5, pp.133~9 (1996)
- Ikeda Y., "Prognostic value of combination assays for CEA and CA 19-9 in gastric cancer", Oncology, 52, pp.483~6 (1995)